What is cervical cancer?
Cervical cancer, also known as cervical carcinoma, is a malignant tumour of the cervix and the second most common gynaecological cancer. As with many other types of cancer, cervical carcinoma does not develop overnight. Rather, it is often preceded by precancerous lesions known as ‘cervical intraepithelial neoplasia’ (CIN), also referred to as ‘dysplasia’. The main cause of cervical cancer is infection with human papillomaviruses, or HPV for short. However, not every HPV infection leads to cervical cancer. The immune system often successfully fights off the viruses. In some women, however, a chronic infection may develop, which can trigger cellular changes and ultimately lead to cervical cancer. However, this process occurs in several stages and usually takes several years. This long period between infection and the possible development of cancer is crucial for screening and early detection. It enables precancerous changes to be detected and treated in good time, before cancer develops. You can find out more about cervical cancer here.
Other risk factors for the development of cervical cancer or an HPV infection include:
- a weakened immune system (e.g. due to conditions such as HIV or certain medicines)
- smoking
- existing precancerous lesions
- additional infections of the genital organs (e.g. chlamydia or genital herpes)
- hormonal contraceptives, such as the pill (there is a slightly increased risk if taken for more than five years)
- frequent changes of sexual partners
- multiple births
What screening tests are available for the early detection of cervical cancer?
Early cancer screening aims to diagnose tumours at a very early stage, often before they cause any symptoms. The earlier a tumour is detected, the easier the treatment is usually, and the chances of a cure increase significantly. There are two key screening tests available for the early detection of cervical cancer:
Pap smear
The Pap smear is a routine gynaecological test for the early detection of cervical cancer and is one of the most successful cancer screening tests in existence. Since the introduction of this test, mortality from cervical cancer has been reduced by two-thirds. A Pap smear enables early detection of cellular changes in the cervix. If these are treated in good time, the development of cancer can be prevented in most cases.
How is a Pap smear carried out?
A Pap smear is a simple, quick and usually painless examination. During the procedure, the doctor swabs the cervix with a soft spatula or brush to collect a small sample of cells. These cells are then stained using the Papanicolaou method and examined under a microscope in the laboratory. In most cases, the results are available within a few days.
What do the results of a Pap smear mean?
The results of a Pap smear are categorised into seven grades: 0, I, II, III, IIID, IVa, IVb and V. Only grades IVa, IVb and V suggest that precancerous changes or cervical cancer itself may be present.
How reliable are the results of a Pap smear?
The Pap smear is generally highly informative, and the results are reliable. However, in around 10 per cent of cases, the test needs to be repeated. Reasons for this may include an existing infection that needs to be treated first, or an insufficient number of cells in the smear.
HPV test
In recent years, the HPV test has become an important part of gynaecological screening. It enables the early detection of human papillomavirus (HPV) infections, which pose a risk of developing cervical cancer.
How is an HPV test carried out?
The HPV test is a simple procedure in which – similar to a Pap smear – a cell sample is taken from the cervix. The sample is then examined in the laboratory for HPV viruses.
What types of HPV tests are there?
There are two types of HPV test:
- Hybridisation test: This determines whether the detected HPV pathogen belongs to a high-risk or low-risk type. High-risk types can lead to the development of certain types of cancer.
- PCR test (polymerase chain reaction): This method can identify the exact types of virus.
How reliable are the results of an HPV test?
The HPV test reliably detects possible precancerous changes and, according to some experts, is even considered more accurate than the Pap smear. The HPV test detects significantly more cases of dysplasia (cell changes); however, this can also lead to the treatment of cell changes that might never have developed into cancer.
Further investigations
A positive Pap smear or HPV test does not automatically mean that cervical cancer is present. It merely indicates that cell changes exist which need to be monitored. If the results are abnormal, more frequent follow-up examinations are necessary, as many cell changes resolve on their own. If this is not the case, further investigations, such as a biopsy, are carried out to determine the nature of the changes more precisely.
What are the benefits of early detection of cervical cancer?
Early detection of cervical cancer has numerous benefits:
- Timely detection of precancerous changes: Cell changes can be detected and treated at an early stage, significantly reducing the risk of developing cancer later on.
- Prevention of serious illness: Treating precancerous changes can prevent the development of invasive cervical cancer. This means that serious illnesses, operations, chemotherapy or radiotherapy can be avoided.
- Less invasive treatments: Treating precancerous changes is less invasive and less stressful than treating advanced-stage cancer.
- Higher chances of recovery: With early diagnosis, the chances of recovery and survival are significantly higher.
- Peace of mind: The assurance that any potential changes will be detected and treated in good time offers many women emotional reassurance and a sense of security.
Are there any disadvantages?
When it comes to the early detection of cervical cancer, there are some aspects that may be considered disadvantages:
- Over-diagnosis and over-treatment: Highly sensitive tests sometimes detect cell changes that resolve on their own or have no clinical significance. This can lead to unnecessary treatments, such as a cone biopsy (conisation).
- Psychological stress: A positive test result can trigger anxiety and worry, even if the changes are harmless.
- Costs: Although screening tests are usually covered by health insurance, additional tests or treatments may sometimes incur costs.
- False-negative results: There is a small risk that significant changes may be overlooked.
Nevertheless, the benefits of cervical cancer screening clearly outweigh the potential drawbacks. A personalised consultation with your doctor will help you to better assess the risks and benefits.
What are the limitations of screening?
Early detection is an important tool, but naturally it also has its limitations:
- Not all HPV types cause cancer: some HPV types are harmless and do not lead to cell changes or cancer.
- Other risk factors: As well as HPV, there are other factors that can contribute to the development of cervical cancer, such as a weakened immune system or smoking.
- Reliability of a single Pap smear: A single Pap smear is not entirely reliable. Around half of all advanced dysplasias may be missed in a single test.
Despite these limitations, early detection remains a crucial component in minimising the risk of cervical cancer.
What other screening measures are available?
A key component of cervical cancer screening is the HPV vaccination. It can significantly reduce the rate of cellular changes in the cervix and thus lower the risk of these developing into precancerous lesions or cervical cancer. The greatest benefit of the vaccination is achieved when it is administered before the first exposure to HPV – ideally, therefore, before a person becomes sexually active. The vaccination protects against the most dangerous types of HPV, but not against all of them. One hundred per cent protection is therefore not possible, and the vaccine cannot reverse existing infections. For these reasons, it is important that even vaccinated women continue to attend regular gynaecological screening appointments to detect any potential changes at an early stage.